Stoke Therapeutics (STOK) Expected to Release Earnings on Monday

Stoke Therapeutics (NASDAQ:STOK) is anticipated to release its Q2 2026 earnings before market open on Monday, August 3rd. Analysts project a loss of $0.82 per share and $4.89 million in revenue. The company's stock, currently trading around $29.20, holds a "Moderate Buy" consensus rating with an average analyst price target of $43.00, while insider selling and institutional investment adjustments have also been noted.